EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication

Xianfeng Hui iD, Xiaowei Tian, Chang Xue, Shihuan Ding, Jiyan Cui, Aiping Sun, Wei Lu, Yunwei Lou, Shaoju Qian, Tiesuo Zhao, Liangwei Duan, Hui Wang iD

Journal of Virology · 21.07.2026 · 100 (7)

DOI: 10.1128/jvi.00481-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 21.07.2026. Verfasst von Xianfeng Hui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Henan Medical University, Xinxiang, China. Hauptthemen laut MEDLINE: Virus Replication, Ubiquitination, Viral Proteins, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province, Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitination is a pivotal regulatory mechanism in host-virus interactions, playing essential roles in both antiviral defense and viral immune evasion, with E3 ubiquitin ligases serving as critical regulatory nodes. In this study, we systematically evaluated 26 candidate host E3 ubiquitin ligases for their involvement in influenza A virus (IAV) infection. Among these, potassium channel modulatory factor 1 (KCMF1) was identified as a novel negative regulator of IAV replication in vitro and in vivo . Mechanistically, KCMF1 interacts with the viral polymerase subunit PB1 and mediates its ubiquitination at lysine 653 (K653), triggering proteasomal degradation and consequent impairment of polymerase activity. A recombinant PR8 (H1N1) virus carrying a K653R substitution in PB1 exhibits enhanced replication and increased pathogenicity in both cells and mice. Furthermore, the inhibitory effect of KCMF1 on PR8 virus replication is dependent on the K653 residue of PB1. Importantly, viruses harboring the PB1 K653 mutation display marked resistance to favipiravir (T-705), an inhibitor of viral RNA-dependent RNA polymerase, suggesting that mutations at this site may influence antiviral drug sensitivity in circulating strains, and have potential implications for clinical treatment and viral surveillance. In conclusion, our findings identify KCMF1 as a host restriction factor that suppresses IAV replication via ubiquitination of PB1 at K653. IMPORTANCE Influenza A virus (IAV) continues to pose a major global health threat, and host factors that regulate viral replication are critical for understanding pathogenesis and guiding antiviral interventions. Here, we identify KCMF1 as a host E3 ubiquitin ligase that restricts IAV replication by promoting ubiquitination-dependent degradation of the viral polymerase subunit PB1. We further define lysine 653 (K653) of PB1 as a critical residue for this regulatory mechanism. Notably, mutation at this site enhances viral replication and pathogenicity while conferring resistance to favipiravir, a clinically approved inhibitor of viral RNA-dependent RNA polymerase. Collectively, these findings provide new mechanistic insights into host–virus interactions and highlight important considerations for antiviral drug use and surveillance of emerging viral variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationUbiquitinationViral ProteinsInfluenza A Virus, H1N1 SubtypeInfluenza A virusAnimalsHumansMiceDogsUbiquitin-Protein LigasesLysineHEK293 CellsHost-Pathogen InteractionsMadin Darby Canine Kidney CellsInfluenza, HumanPyrazinesOrthomyxoviridae InfectionsAntiviral Agents

Stichwörter der Autor:innen

E3 ubiquitin ligaseK653 sitePB1 proteinimmune defenseinfluenza A virusubiquitin

Substanzen

Viral Proteinsinfluenza virus polymerase basic protein 1Ubiquitin-Protein LigasesLysinePyrazinesAntiviral Agents

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, Henan Medical University, Xinxiang, China.
  • Henan Key Laboratory of Immunology and Targeted Drug, Henan Medical University, Xinxiang, China.
  • Xinxiang Engineering Technology Research Center of Immune Checkpoint Drug for Liver-Intestinal Tumors, Henan Medical University, Xinxiang, China.
  • Department of Pathogenic Biology, School of Basic Medical Sciences, Henan Medical University, Xinxiang, China.
  • Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Medical Technology, Henan Medical University, Xinxiang, China.

ORCID-Profile: Xianfeng Hui, Hui Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Henan Province
  • Henan Provincial Science and Technology Research Project
  • Key Scientific Research Project of Colleges and Universities in Henan Province
  • Overseas Expertise Introduction Project for Discipline Innovation

Zitieren

APA

Hui, X., Tian, X., Xue, C., Ding, S., Cui, J., Sun, A., Lu, W., Lou, Y., Qian, S., Zhao, T., Duan, L., & Wang, H. (2026). KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication. Journal of Virology, 100(7). https://doi.org/10.1128/jvi.00481-26

Vancouver

Hui X, Tian X, Xue C, Ding S, Cui J, Sun A, et al. KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication. Journal of Virology. 2026;100(7). doi:10.1128/jvi.00481-26

BibTeX
@article{Hui2026,
  author = {Hui, Xianfeng and Tian, Xiaowei and Xue, Chang and Ding, Shihuan and Cui, Jiyan and Sun, Aiping and Lu, Wei and Lou, Yunwei and Qian, Shaoju and Zhao, Tiesuo and Duan, Liangwei and Wang, Hui},
  title = {KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication},
  journal = {Journal of Virology},
  year = {2026},
  volume = {100},
  number = {7},
  doi = {10.1128/jvi.00481-26}
}
Kostenlos starten →